The liver plays a major role in clearance and destruction of blood trypomastigotes in Trypanosoma cruzichronically infected mice

PLoS Neglected Tropical Diseases

Volumn 4, Issue 1, 2010, Pages

  Sardinha, Luiz Roberto ^a   Mosca, Tainá ^a   Elias, Rosa Maria ^a   Do Nascimento, Rogério Silva ^a   Gonçalves, Lígia A ^b   Bucci, Daniella Zanetti ^a   Marinho, Cláudio Romero Farias ^a   Penha Gonçalves, Carlos ^b   Lima, Maria Regina D'Império ^a   Álvarez, José Maria ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 2 RECEPTOR BETA; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; BLOOD PARASITE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CHAGAS DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; IMMUNE RESPONSE; IN VITRO STUDY; LIVER; LIVER CELL; LIVER PARENCHYMA; LIVER PROTECTION; MOUSE; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE; PHENOTYPE; PLASMA CLEARANCE; POLYMERASE CHAIN REACTION; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE; ANIMAL; C57BL MOUSE; CYTOLOGY; GENETICS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; PARASITOLOGY; PHYSIOLOGY;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHAGAS DISEASE; FEMALE; IMMUNOHISTOCHEMISTRY; INTERFERON-GAMMA; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-2 RECEPTOR BETA SUBUNIT; KILLER CELLS, NATURAL; LIVER; MICE; MICE, INBRED C57BL; POLYMERASE CHAIN REACTION; TRYPANOSOMA CRUZI;

EID: 76249090411     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000578     Document Type: Article

References (34)

1. Avila HA, Sigman DS, Cohen LM, Millikan RC, Simpson L (1991) Polymerase chain reaction amplification of Trypanosoma cruzi kinetoplast minicircle DNA isolated from whole blood lysates: diagnosis of chronic Chagas' disease. Mol Biochem Parasitol 48: 211-221.
2. Marinho CR, Bastos KR, Sardinha LR, Grisotto MG, Lima MR, et al. (2004) Challenge of Trypanosoma cruzi chronically infected mice with trypomastigotes activates the immune system and reduces subpatent parasitemia levels. J Parasitol 90: 516-523.
3. Marinho CR, Bucci DZ, Dagli ML, Bastos KR, Grisotto MG, et al. (2004) Pathology affects different organs in two mouse strains chronically infected by a Trypanosoma cruzi clone: a model for genetic studies of Chagas' disease. Infect Immun 72: 2350-2357.
4. Russo M, Starobinas N, Marcondes MC, Minoprio P, Honteyberie-Joskowicz M (1996) The influence of T cell subsets on Trypanosoma cruzi multiplication in different organs. Immunol Lett 49: 163-168.
5. Rottenberg ME, Bakhiet M, Olsson T, Kristensson K, Mak T, et al. (1993) Differential susceptibilities of mice genomically deleted of CD4 and CD8 to infections with Trypanosoma cruzi or Trypanosoma brucei. Infect Immun 61: 5129-5133.
6. Tarleton RL, Koller BH, Latour A, Postan M (1992) Susceptibility of beta 2-microglobulin-deficient mice to Trypanosoma cruzi infection. Nature 356: 338-340.
7. Nickell SP, Sharma D (2000) Trypanosoma cruzi: roles for perforin-dependent and perforin-independent immune mechanisms in acute resistance. Exp Parasitol 94: 207-216.
8. Plata F, Wietzerbin J, Pons FG, Falcoff E, Eisen H (1984) Synergistic protection by specific antibodies and interferon against infection by Trypanosoma cruzi in vitro. Eur J Immunol 14: 930-935.
9. de Titto EH, Cardoni RL (1983) Trypanosoma cruzi: parasite-induced release of lysosomal enzymes by human polymorphonuclear leukocytes. Exp Parasitol 56: 247-254.
10. Umekita LF, Carneiro SM, Sesso A, Mota I (1999) One fate of bloodstream trypomastigote forms of Trypanosoma cruzi after immune clearance: an ultrastructural study. J Parasitol 85: 867-872.
11. Umekita LF, Takehara HA, Mota I (1988) Role of the antibody Fc in the immune clearance of Trypanosoma cruzi. Immunol Lett 17: 85-89.
12. Mota I, Umekita LF (1989) The effect of C3 depletion on the clearance of Trypanosoma cruzi induced by IgG antibodies. Immunol Lett 21: 223-225.
13. Sardinha LR, Elias RM, Mosca T, Bastos KR, Marinho CR, et al. (2006) Contribution of NK, NK T, gammadelta T, and alphabeta T cells to the gamma interferon response required for liver protection against Trypanosoma cruzi. Infect Immun 74: 2031-2042.
14. Crispe IN (1996) Isolation of mouse intrahepatic lymphocytes. Current Protocols in Immunology 3: 22-28.
15. Garcia IE, Lima MR, Marinho CR, Kipnis TL, Furtado GC, et al. (1997) Role of membrane-bound IgM in Trypanosoma cruzi evasion from immune clearance. J Parasitol 83: 230-233.
16. Marinho CR, D'Imperio Lima MR, Grisotto MG, Alvarez JM (1999) Influence of acute-phase parasite load on pathology, parasitism, and activation of the immune system at the late chronic phase of Chagas' disease. Infect Immun 67: 308-318.
17. Biermann H, Pietz B, Dreier R, Schmid KW, Sorg C, et al. (1999) Murine leukocytes with ring-shaped nuclei include granulocytes, monocytes, and their precursors. J Leukoc Biol 65: 217-231.
18. Ziegler SF, Levin SD, Johnson L, Copeland NG, Gilbert DJ, et al. (1994) The mouse CD69 gene. Structure, expression, and mapping to the NK gene complex. J Immunol 152: 1228-1236.
19. Minami Y, Kono T,Miyazaki T, Taniguchi T (1993) The IL-2 receptor complex: its structure, function, and target genes. Annu Rev Immunol 11: 245-268.
20. Kennedy MK, Park LS (1996) Characterization of interleukin-15 (IL-15) and the IL-15 receptor complex. J Clin Immunol 16: 134-143.
21. Turka LA, Walsh PT (2008) IL-2 signaling and CD4+ CD25+ Foxp3+ regulatory T cells. Front Biosci 13: 1440-1446.
22. Gazzinelli RT, Oswald IP, Hieny S, James SL, Sher A (1992) The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta. Eur J Immunol 22: 2501-2506.
23. Laucella SA, Postan M, Martin D, Hubby Fralish B, Albareda MC, et al. (2004) Frequency of interferon- gamma -producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease. J Infect Dis 189: 909-918. Epub 2004 Feb 2017.
24. Plata F, Garcia-Pons F, Wietzerbin J (1987) Immune resistance to Trypanosoma cruzi: synergy of specific antibodies and recombinant interferon gamma in vivo. Ann Inst Pasteur Immunol 138: 397-415.
25. Umekita LF, Mota I (2000) How are antibodies involved in the protective mechanism of susceptible mice infected with T. cruzi? Braz J Med Biol Res 33: 253-258.
26. Surh CD, Sprent J (2008) Homeostasis of naive and memory T cells. Immunity 29: 848-862.
27. Higuchi MD, Ries MM, Aiello VD, Benvenuti LA, Gutierrez PS, et al. (1997) Association of an increase in CD8+ T cells with the presence of Trypanosoma cruzi antigens in chronic, human, chagasic myocarditis. Am J Trop Med Hyg 56: 485-489.
28. Sun J, Tarleton RL (1993) Predominance of CD8+ T lymphocytes in the inflammatory lesions of mice with acute Trypanosoma cruzi infection. Am J Trop Med Hyg 48: 161-169.
29. Reis DD, Jones EM, Tostes S Jr, Lopes ER, Gazzinelli G, et al. (1993) Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: presence of tumor necrosis factor-alpha+ cells and dominance of granzyme A+, CD8+ lymphocytes. Am J Trop Med Hyg 48: 637-644.
30. Grisotto MG, D'Imperio Lima MR, Marinho CR, Tadokoro CE, Abrahamsohn IA, et al. (2001) Most parasite-specific CD8+ cells in Trypanosoma cruzi-infected chronic mice are down-regulated for T-cell receptor-alphabeta and CD8 molecules. Immunology 102: 209-217.
31. Martin DL, Tarleton RL (2005) Antigen-specific T cells maintain an effector memory phenotype during persistent Trypanosoma cruzi infection. J Immunol 174: 1594-1601.
32. Bixby LM, Tarleton RL (2008) Stable CD8+ T cell memory during persistent Trypanosoma cruzi infection. J Immunol 181: 2644-2650.
33. Alcantara A, Brener Z (1978) The in vitro interaction of Trypanosoma cruzi bloodstream forms and mouse peritoneal macrophages. Acta Trop 35: 209-219.
34. Marinho CR, Nunez-Apaza LN, Martins-Santos R, Bastos KR, Bombeiro AL, et al. (2007) IFN-gamma, but not nitric oxide or specific IgG, is essential for the in vivo control of low-virulence Sylvio X10/4 Trypanosoma cruzi parasites. Scand J Immunol 66: 297-308.